Phibro Animal Health | Passivo Circulante



Current Liabilities Alterar Data
Align Technology USD 1.99B 47.08M 2025-03
ANI Pharmaceuticals USD 201.82M 8.14M 2025-03
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 143.07M 2.29M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Henry Schein USD 2.92B 114M 2025-03
Idexx Laboratories USD 1.14B 68.3M 2025-03
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Merck USD 25.17B 3.25B 2025-03
Pacira USD 314.73M 4.81M 2025-03
Prestige Brands USD 106.62M 4.08M 2025-03
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Zoetis USD 3.38B 27M 2025-03



Phibro Animal Health Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.